Aprea Therapeutics Inc (APRE) Insider Trading

Total insider buys:
  • $9,454,314.84
Total insider sells:
  • $44,682,646.29
Most recent insider trade:
  • Oct. 23, 2024
Most active insider trader:
  • Oren Gilad
Trader NameDateTitleAmountPriceTypeTotal Value
Oct. 23, 2024CEO500$3.92Buy$1,960.00
Oct. 16, 2024Director30,000$4.39Buy$131,700.00
Oct. 14, 2024CEO1,000$2.59Buy$2,590.00
Oct. 14, 2024Director190$2.58Buy$490.20
Oct. 11, 2024Director10,000$2.68Buy$26,800.00
Oct. 10, 2024CEO150$2.54Buy$381.00
Oct. 10, 2024CFO450$2.61Buy$1,174.50
March 13, 2024CEO2,000$7.29Buy$14,580.00
March 13, 2024Director6,860$7.29Buy$50,009.40
March 13, 2024CFO1,010$7.29Buy$7,362.90
June 6, 2023Director4,068$3.63Buy$14,766.84
Feb. 28, 2022SVP36,000$1.73Sell$62,280.00
Dec. 1, 2021SVP27,500$3.96Sell$108,900.00
Oct. 1, 2021SVP50,000$4.89Sell$244,500.00
Sept. 20, 2021SVP32,960$4.97Sell$163,811.20
Sept. 16, 2021SVP15,968$4.68Sell$74,730.24
Oct. 5, 2020Insider175,000$25.30Sell$4,427,500.00
July 7, 2020Major Shareholder241,703$34.55Sell$8,350,838.65
June 16, 2020Major Shareholder140,000$33.30Sell$4,662,000.00
June 16, 2020Director120,164$33.30Sell$4,001,461.20
June 11, 2020Director245,000$28.75Sell$7,043,750.00
May 19, 2020Director255,000$35.15Sell$8,963,250.00
April 13, 2020Major Shareholder210,548$31.25Sell$6,579,625.00
Oct. 7, 2019Director266,667$15.00Buy$4,000,005.00
Oct. 7, 2019Major Shareholder333,333$15.00Buy$4,999,995.00
Oct. 7, 2019CFO2,500$15.00Buy$37,500.00
Oct. 7, 2019CEO11,000$15.00Buy$165,000.00
First«1 of 1»Last
  • Insiders are both buying and selling Aprea Therapeutics Inc stock.

  • The insider traders at Aprea Therapeutics Inc are: Oren Gilad, Scott M Rocklage, Bernd R Seizinger, John P Hamill, Kdev Investments Ab, Marc Duey, Ventures Iv L.P. 5Am, Eyal C Attar, Gregory Alan Korbel, Lars B Abrahmsen, Scott M Coiante, Johan Christenson, Vantage I L.P. Versant, and Christian S Schade

  • The most active insider trader at Aprea Therapeutics Inc is Oren Gilad with 4 trades.

  • Scott M Rocklage has sold the most Aprea Therapeutics Inc stock with a total value of $24,009,922.40.

  • Vantage I L.P. Versant has bought the most Aprea Therapeutics Inc stock with a total value of $9,999,990.00.

  • The most recent insider trade for Aprea Therapeutics Inc was on Oct. 23, 2024.

  • The single biggest insider buy for Aprea Therapeutics Inc was from Vantage I L.P. Versant with a total value of $4,999,995.00 on Oct. 7, 2019.

  • The single biggest insider sell for Aprea Therapeutics Inc was from Scott M Rocklage with a total value of $8,963,250.00 on May 19, 2020.